Medicare (and Medicare Advantage) provide some coverage for dementia, beginning with the diagnosis, says Baumgart.

The FDA approved donanemab, which will be sold under the brand name Kisunla. The new drug helps slow decline in Alzheimer's patients with mild cognitive impairment.

Called Donanemab, this treatment from Eli Lilly will be sold under its brand name, Kisunla, and works as an intravenous ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips The stock market continues to demonstrate strong performance, ...

Kisunla is used to treat adults with early symptomatic Alzheimer’s disease, which includes mild cognitive impairment and mild dementia. “This is real progress,” said Dr. Joanne Pike, Alzheimer’s ...

Roche’s recent $2.7 billion acquisition of Carmot Therapeutics is paying off, with positive results for new oral GLP-1 ...

Contract development and manufacturing organizations (CDMOs) perform vital services for the biopharmaceutical industry – a ...

South Korea’s Supreme Court has accorded new rights to same-sex couples, ruling on Thursday that gay partners must receive state health insurance, a landmark decision that drew celebratory tears ...

Subscribe to Sky Sports to watch live, or stream on NOW. You'll need a subscription that includes Sky Sports News.